Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis
Daniel K. Nomah(Universitat Autònoma de Barcelona), José M Miró(Instituto de Salud Carlos III), Francisco Fanjul(Hospital Universitario Son Espases), Elisabet Deig, Arkaitz Imaz(Bellvitge University Hospital), Alexy Inciarte(Universitat de Barcelona), Vicenç Falcó(Universitat Autònoma de Barcelona), Jordi Aceitón(Generalitat de Catalunya), Peré Domingo(Hospital de Sant Pau), Juliana Reyes‐Urueña(Generalitat de Catalunya), Yesika Díaz(Institut Universitari d'Investigació en Atenció Primària Jordi Gol), Andreu Bruguera(Badalona Serveis Assistencials), Jordi Casabona(Centro de Estudios Políticos y Constitucionales), Sergio Moreno‐Fornés(Generalitat de Catalunya), Joaquim Peraire(Instituto de Salud Carlos III), Josep M. Llibre(Badalona Serveis Assistencials)
Cited by 3
Related Papers
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143
Relationship between current level of immunodeficiency and non‐acquired immunodeficiency syndrome‐defining malignancies
|Cancer|2010|141
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137